Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema

Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema

Abstract Background To evaluate the additive effect of topical or sub-tenon injection of interferon (IFN)-α 2b in the treatment of refractory diabetic macular edema. Methods In this prospective study patients with center-involved DME who were unresponsive to 3 monthly consecutive IVB injections were...

Full description

Bibliographic Details
Main Authors: Hooshang Faghihi, Bahman Inanloo, Arash Mirzaee, Kaveh Fadakar, Ahmad Mirshahi, Nazanin Ebrahimiadib, Fariba Ghassemi, Fatemeh Bazvand, Abdulrahman Amini, Masoud Mirghorbani, Shahin Faghihi, Elias Khalili Pour, Hamid Riazi-Esfahani
Format: Article
Language:English
Published: BMC 2022-10-01
Series:International Journal of Retina and Vitreous
Subjects:
Diabetic retinopathy
Refractory diabetic macular edema
Interferon-alpha
Anti-vascular endothelial growth factor (Anti-VEGF)
Online Access:https://doi.org/10.1186/s40942-022-00424-x

Internet

https://doi.org/10.1186/s40942-022-00424-x

Similar Items